DTWD1

Across TCGA pan-cancer cohorts, DTWD1 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of DTWD1’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where DTWD1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types DTWD1 is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.

LSCC, PDAC, and CCRCC are the cancer types where DTWD1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DTWD1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Female	All	+0.407	<.001	9	view →
PDAC	All	All	+0.280	.006	5	view →
CCRCC	All	All	+0.279	<.001	5	view →
LUAD	Female	All	−0.124	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

DTWD1–LSCC

Open the LSCC breakdown →